Recent Finacing
Recent Raise
Oncoinvent is a clinical-stage radiopharmaceutical company developing radium-224 alpha-emitting microspheres (Radspherin) to treat metastatic cancers in body cavities, with internal radioisotope manufacturing and a targeted therapeutics pipeline.
